Literature DB >> 10476044

Cell death and oxidative stress in gliomas.

D S Tews1.   

Abstract

In gliomas, apoptosis and necrosis are determined by a number of promoting and inhibiting factors including oxidative cell stress mediated by nitric oxide synthases (NOS) and reduced by superoxide dismutases. Therefore, in 46 gliomas (including astrocytomas, oligodendrogliomas, oligo-astrocytomas, and glioblastomas), the relationship of apoptosis and necrosis and the expression of apoptosis-promoting (p53, bax, Fas, Fas-L) and inhibiting (bcl-2) factors as well as of different isoforms of NOS (NOSb, NOSe, NOSi) and manganese superoxide dismutase (MnSOD) were studied. Apoptosis was measured in situ by the TUNEL method while expression profiles of apoptosis-related and oxidative stress-associated factors were determined by immunohistochemistry. As a defining criterion, necrosis was restricted to glioblastomas while apoptosis increased with tumour malignancy (P=0.017) in all types of gliomas. Glial tumour cells displayed upregulation of bax, Fas, Fas-L, p53, and bcl-2 but with no significant correlation with malignancy. There was also a strong expression of NOS isoforms with upregulation of NOSe in all and of NOSb and NOSi in nearly 50% of the tumour specimens but only NOSb expression correlated significantly with tumour malignancy (P=0.004). Likewise, MnSOD was strongly expressed in all gliomas but was not correlated with tumour grade. There was a wide variability of expression in each tumour type without significant correlation between apoptosis and expression of apoptosis-associated or oxidative stress-related factors indicating that the network of regulating factors may be too complex for clear associations.

Entities:  

Mesh:

Year:  1999        PMID: 10476044     DOI: 10.1046/j.1365-2990.1999.00186.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  9 in total

1.  Bcl-2 expression in higher-grade human glioma: a clinical and experimental study.

Authors:  C Fels; C Schäfer; B Hüppe; H Bahn; V Heidecke; C M Kramm; C Lautenschläger; N G Rainov
Journal:  J Neurooncol       Date:  2000-07       Impact factor: 4.130

2.  Lipid peroxidation and activity of some antioxidant enzymes in patients with glioblastoma and astrocytoma.

Authors:  Bartosz Woźniak; Alina Woźniak; Heliodor A Kasprzak; Gerard Drewa; Celestyna Mila-Kierzenkowska; Tomasz Drewa; Grzegorz Planutis
Journal:  J Neurooncol       Date:  2006-06-14       Impact factor: 4.130

3.  Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.

Authors:  D S Tews; A Nissen; C Külgen; A K Gaumann
Journal:  J Neurooncol       Date:  2000-12       Impact factor: 4.130

Review 4.  Apoptosis in gliomas: molecular mechanisms and therapeutic implications.

Authors:  Joachim P Steinbach; Michael Weller
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

Review 5.  Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis.

Authors:  Nadine Hempel; Pauline M Carrico; J Andres Melendez
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

Review 6.  Mechanisms of apoptosis in central nervous system tumors: application to theory.

Authors:  Joachim P Steinbach; Michael Weller
Journal:  Curr Neurol Neurosci Rep       Date:  2002-05       Impact factor: 5.081

7.  The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation.

Authors:  Dorota M Olszewska-Słonina; Dariusz Mątewski; Rafał Czajkowski; Krzysztof J Olszewski; Alina Woźniak; Grażyna Odrowąż-Sypniewska; Kinga Lis; Dariusz Musiałkiewicz; Bogna Kowaliszyn
Journal:  Med Sci Monit       Date:  2011-09

Review 8.  Insights into the Dichotomous Regulation of SOD2 in Cancer.

Authors:  Yeon Soo Kim; Piyushi Gupta Vallur; Rébécca Phaëton; Karthikeyan Mythreye; Nadine Hempel
Journal:  Antioxidants (Basel)       Date:  2017-11-03

9.  Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development.

Authors:  Marina Kazantseva; Ramona A Eiholzer; Sunali Mehta; Ahmad Taha; Sara Bowie; Imogen Roth; Jean Zhou; Sebastien M Joruiz; Janice A Royds; Noelyn A Hung; Tania L Slatter; Antony W Braithwaite
Journal:  J Pathol       Date:  2018-07-31       Impact factor: 7.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.